Could a higher dose keep more people in opioid treatment?
NCT ID NCT06316830
First seen Nov 01, 2025 · Last updated May 17, 2026 · Updated 27 times
Summary
This study compares a higher daily dose of buprenorphine (24 mg) to the standard dose (16 mg) in 250 adults with opioid use disorder who have used fentanyl. The goal is to see if the higher dose helps people stay in treatment longer and reduces cravings and overdose risk. Participants will be followed for six months to track retention and opioid use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPIOID USE DISORDER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Brown University
RECRUITINGProvidence, Rhode Island, 02912, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.